RG6333 (CD19-CD28), a CD19-Targeted Affinity-Optimized CD28 Bispecific Antibody, Enhances and Prolongs the Anti-Tumor Activity of Glofitamab (CD20-TCB) in Preclinical Models

Autor: Sam, Johannes *, Hofer, Thomas *, Kuettel, Christine *, Claus, Christina *, Herter, Sylvia *, Georges, Guy *, Thom, Jenny Tosca *, Kunz, Leo *, Gebhardt, Samuel *, Limani, Florian *, Briner, Stefanie *, Jenni, Silvia *, Schönle, Anne *, Le Clech, Marine *, Varol, Ahmet *, Bommer, Esther *, Appelt, Birte *, Colombetti, Sara *, Gasser, Stephan *, Bacac, Marina *, Klein, Christian, Umana, Pablo
Zdroj: In Blood 15 November 2022 140 Supplement 1:3142-3143
Databáze: ScienceDirect